BioSpace News Archive

Olink Holding AB announced it will release financial results for the second quarter of 2023 before the market open on Wednesday, August 9, 2023.

Recce Pharmaceuticals Ltd is pleased to announce it received further non-dilutive funds from Radium Capital for A$801,604 of Recce’s future R&D tax incentive.

MaxCyte, Inc. today announced that it will release financial results for the second quarter 2023 after the U.S. market close on Wednesday, August 9th, 2023.

3Daughters announces key senior leadership appointments and the formation of a Scientific Advisory Board to support the development of its lead asset, a highly innovative and frameless intrauterine device for contraception.

Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced the completion of the previously announced transaction that establishes a strategic relationship with Jefferson Health ( Jefferson ), the largest health system serving the greater Philadelphia and Southern New Jersey.

Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for Lynparza® (olaparib) in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with deleterious or suspected deleterious germline and/or somatic BRCA.

Convergent Imaging Solutions, a leader in workflow optimized medical image fusion and nuclear medicine software, announced that it has won the public tender for nuclear medicine processing software at Hôpital Montfort, in Ottawa, Canada.

Bausch Health Companies Inc. (NYSE/TSX:BHC) will release its second-quarter financial results on Thursday, Aug. 3, 2023.

International Foundation for Gastrointestinal Disorders raises awareness for Gastroparesis Awareness Month to shed light on the varied impact on the quality of life for individuals.

Propanc Biopharma, Inc. announced that a peer reviewed scientific article published by the Company and its research partners reached 3,000 reads on July 6, 2023, according to ResearchGate.